Life Science Leader Blogs

  1. Presenting The CMO Leadership Awards — A Humbling Experience In Trust

    I imagine it's a rare occurrence for someone to pause and ponder if what they are putting into or on their body to be safe. As human beings, we place a high degree of faith in the companies that manufacture the BioPharmaceutical products we use on a daily basis. 

  2. Where Do Good Ideas Come From?

    We often refer to innovation in the business world as having a link to serendipity. “We just happened to be in the right place at the right time — a lucky break.” But is this really the case? 

  3. Valor For Invention

    A lot of discussion at Biocom’s Global Partnering Conference about large companies’ continuing inability to deal with risk. I’m not reflecting public perception here, but the opinions of people in the industry, in companies large and small.

  4. Pharma — Frozen in Place or Running from the Past?

    We editors have debates about whether Pfizer is pharma or “biopharma.” After all, what self-respecting Big Pharma would risk being caught dead these days with no biotech-based products? Does that mean they have all outgrown the pharma label?

  5. Does A Full Room At BIO CEO Indicate A Company Past Its Tipping Point?

    Follow the Twitter hashtag #BIOCEO15 and look for the tweets touting “standing room only” to determine the companies investors consider hot at the 7th Annual BIO CEO & Investor Conference.

  6. A Behind The Scenes Look At The 2015 J.P. Morgan Healthcare Conference

    At the 3rd Annual J.P. Morgan Healthcare Conference (JPM) if you want to gather the vital statistics on how a biopharmaceutical company’s leadership team really feels, from my perspective, the best place to do so is during the much-less-scripted JPM breakout sessions — assuming of course, you can get a seat.

  7. Bio By The Bay — Science Means Business

    Somebody better teach these start-up executives how to run a company — and FAST! No clearer rationale was needed for the San Francisco Bay Area industry group, the BayBio Institute, to get moving with its FAST (Fellows All-Star Team) mentoring program to serve the leaders of BayBio’s smallest member companies, or Fellows.

  8. Can We Really Trust “Greedy” Drug Development Companies To Find Cures?

    Some of the industry’s misdeeds discussed at this year’s FDA/CMS Summit include “price gouging” of approved breakthroughs drugs, using approved Risk Evaluation and Mitigation Strategies (REMS) to prevent generic competition, and arguing that distribution of peer-reviewed journal articles and medical textbooks to practicing clinicians should be protected by the first amendment of the constitution. 

  9. Why Outsourced Pharma West 2014 Proved Pivotal In Connecting Collaborators

    When I think of why I go to a conference, it isn’t usually geared toward filling my rolodex with a collection of business cards with which I struggle to place a name with a face. Instead, I strive to fill my network with connections of potential collaborators who are also interested in moving our industry forward. From my perspective, this was most certainly achieved at Outsourced Pharma West (OPW) 2014.

  10. Do You Have A Future In Leadership?

    While preparing for a recent trip to the west coast, I packed a copy of Leaders in Transition by Steve Broe. Author of a leadership lessons article in Life Science Leader magazine’s December 2014 issue, Broe was kind enough to send me a signed copy of his book. Although it is written from the perspective of a leader transitioning from one organization to another, even if leaving your current employer is not in your plans, don’t let this fact prevent you from taking the time to review this book.